A nurse is providing teaching to a group of expectant parents about risk factors for sudden infant death syndrome. Which of the following risk factors should the nurse include?

A) A potassium supplement: Administering a potassium supplement would be inappropriate for a client with a potassium level of 6.4 mEq/L. This level is above the normal range (3.5-5.0 mEq/L) and indicates hyperkalemia, which can have serious effects on cardiac function. Increasing potassium intake could exacerbate the condition.

B) A fiber supplement: While fiber supplements can be beneficial for overall digestive health, they do not directly address or correct an electrolyte imbalance like hyperkalemia. They are not relevant in managing elevated potassium levels.

C) An anticonvulsant: Anticonvulsants are used to manage seizure activity and are not indicated for treating hyperkalemia. They do not have any role in the regulation or management of potassium levels in the body.

D) A diuretic: Diuretics, particularly loop diuretics, are often used to help manage hyperkalemia by promoting the excretion of potassium through urine. This helps lower the elevated potassium levels in the blood and reduce the risk of complications such as cardiac arrhythmias. Therefore, administering a diuretic is an appropriate intervention for a client with a potassium level of 6.4 mEq/L.

A) "Monitor for manifestations of hypoglycemia":
Glipizide is a sulfonylurea, which works by increasing insulin secretion from the pancreas. This can lower blood glucose levels, potentially leading to hypoglycemia. Therefore, it's essential for the client to be aware of and monitor for symptoms such as sweating, shakiness, confusion, and dizziness to manage and treat hypoglycemia promptly.

B) "Take this medication at bedtime":
Glipizide is typically taken before meals to stimulate insulin secretion in response to food intake, helping control postprandial blood glucose levels. Taking it at bedtime is not recommended as it might not be as effective and could increase the risk of nighttime hypoglycemia.

C) "Weigh yourself weekly to monitor for weight loss":
While weight monitoring is important for managing diabetes, glipizide does not commonly cause weight loss. In fact, it may sometimes lead to weight gain. Therefore, this instruction is less relevant than monitoring for hypoglycemia.

D) "Plan to continue to take over-the-counter medications as needed":
Over-the-counter medications can interact with glipizide, potentially affecting blood glucose levels or increasing the risk of side effects. The client should consult with their healthcare provider before taking any new medications. This instruction does not address the primary concern of hypoglycemia management.